Published in J Virol on July 28, 2010
Review on the relationship between human polyomaviruses-associated tumors and host immune system. Clin Dev Immunol (2012) 0.81
Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity. Oncotarget (2016) 0.79
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA. J Virol (2011) 0.77
Immunotherapy of WAP-TNP mice with early stage mammary gland tumors. Oncotarget (2017) 0.75
Immunity, inflammation, and cancer. Cell (2010) 28.27
Fcgamma receptors: old friends and new family members. Immunity (2006) 5.60
Cancer immunology. N Engl J Med (2008) 5.22
Toll-like receptors and cancer. Nat Rev Cancer (2008) 4.29
FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity (2005) 4.22
A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol (2009) 4.19
Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer (2008) 2.89
Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol (2008) 2.70
Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol (2009) 2.44
Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene (1994) 2.21
TLR signaling by tumor and immune cells: a double-edged sword. Oncogene (2008) 2.18
Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells. Int J Cancer (1969) 1.72
Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J Exp Med (2009) 1.67
Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J Immunol (2008) 1.42
Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol (2009) 1.42
Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma. J Immunol (2005) 1.33
A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res (1998) 1.30
Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol Immunol (2005) 1.19
Killers and beyond: NK-cell-mediated control of immune responses. Eur J Immunol (2008) 1.15
Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies. Oncogene (2008) 0.93
Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen. Cancer Res (1996) 0.93
SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol Immunother (2001) 0.90
Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase. J Virol (2009) 0.89
Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases. J Virol (2006) 0.87
CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen. Cancer Res (2003) 0.87
Towards progress on DNA vaccines for cancer. Cell Mol Life Sci (2007) 0.87
Quantitation of tumor foci in an experimental murine tumor model using computer-assisted video imaging. Anal Biochem (1998) 0.86
Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice. Cancer Immunol Immunother (2007) 0.86
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. Virology (2005) 0.85
Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells. J Immunol (1987) 0.82
Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen. J Virol Methods (1997) 0.81
Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis. Cancer Immunol Immunother (1999) 0.81
SV40 large T antigen-specific human T cell memory responses. J Med Virol (2008) 0.77
OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients. J Clin Microbiol (2002) 1.41
Cutting edge: class I presentation of host peptides following HIV infection. J Immunol (2003) 1.18
Growth and mycotoxin production by Chaetomium globosum. Mycopathologia (2007) 1.04
Experimental vaccines in animal models for schistosomiasis. Parasitol Res (2008) 1.04
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine (2009) 1.04
Vaccines and immunotherapeutics for the treatment of malignant disease. Clin Dev Immunol (2010) 1.04
Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon. Vaccine (2005) 1.00
Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. J Infect Dis (2010) 0.99
Studies on the role of fungi in Sick Building Syndrome. Arch Environ Health (2003) 0.90
Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases. Cancer Res (2005) 0.90
SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol Immunother (2001) 0.90
Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase. J Virol (2009) 0.89
CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen. Cancer Res (2003) 0.87
Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases. J Virol (2006) 0.87
Activation of focal adhesion kinase in adenovirus-infected human corneal fibroblasts. Invest Ophthalmol Vis Sci (2002) 0.86
DNA vaccines: successes and limitations in cancer and infectious disease. J Cell Biochem (2006) 0.85
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. Virology (2005) 0.85
INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling. Cancer Cell Int (2009) 0.84
Sperm protein 17 is a suitable target for adoptive T-cell-based immunotherapy in human ovarian cancer. J Immunother (2008) 0.83
The conjunctival lymphoid follicle in mucosal immunology. DNA Cell Biol (2002) 0.82
Characterization of gamma-butyrolactone autoregulatory signaling gene homologs in the angucyclinone polyketide WS5995B producer Streptomyces acidiscabies. J Bacteriol (2009) 0.82
Is HIV involved in the pathogenesis of non-infectious pulmonary complications in infected patients? Curr HIV Res (2003) 0.81
A role for antibodies in tumor immunity. Int Rev Immunol (2003) 0.81
Growth and mycotoxin production by Chaetomium globosum is favored in a neutral pH. Int J Mol Sci (2008) 0.80
Characterization of exposure to low levels of viable Penicillium chrysogenum conidia and allergic sensitization induced by a protease allergen extract from viable P. Chrysogenum conidia in mice. Int Arch Allergy Immunol (2003) 0.79
Synthetic AIDS vaccine by targeting HIV receptor. Vaccine (2002) 0.78
Mold contamination and air handling units. J Occup Environ Hyg (2007) 0.78
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity. Cancer Immunol Immunother (2004) 0.78
Structural and cellular architecture of conjunctival lymphoid follicles in the baboon (Papio anubis). Exp Eye Res (2003) 0.78
Neutralizing antibody induced in mice by novel glycoconjugates of human immunodeficiency virus type 1 gp120 and env2-3. J Infect Dis (2002) 0.77
A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. J Immunol Methods (2007) 0.77
Infection of baboon microglia with SIV-HIV recombinant viruses: role of CD4 and chemokine receptors. AIDS Res Hum Retroviruses (2002) 0.77
Evidence of simian virus 40 exposure in a colony of captive baboons. Virology (2008) 0.77
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA. J Virol (2011) 0.77
Detection of macrocyclic trichothecene mycotoxin in a caprine (goat) tracheal instillation model. Toxicol Ind Health (2009) 0.76
Low-dose oral interferon α possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients. Thorax (2010) 0.76
Prognosis of metastatic carcinoma of the lung in the bevacizumab era: comparison between the major histologic types of lung cancer. J Surg Res (2011) 0.76
Immunological treatment of liver tumors. World J Gastroenterol (2005) 0.75
Multilobar lung infiltrates after exposure to dust storm: the Haboob Lung Syndrome. Am J Med (2013) 0.75
Acneiform eruption induced by Iressa (gefitinib) tablets used to treat non-small cell lung cancer. J Drugs Dermatol (2004) 0.75
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen. Cancer Immunol Immunother (2012) 0.75
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. Int J Cancer (2007) 0.75
Monoclonal antibody testing. J Med Primatol (2006) 0.75